동물 유전학 시장 예측(-2031년) : 생체 동물, 제품 및 서비스(유전 물질), 유전자 검사 서비스, 기술, 최종사용자별

The global animal genetics market was valued at USD 6.64 billion in 2026 and is projected to reach USD 9.37 billion by 2031, growing at a CAGR of 7.1% during the forecast period. This is driven by rising demand for high-quality animal protein and dairy products, increasing focus on livestock productivity, and growing adoption of genomic selection, SNP genotyping, and molecular breeding technologies. These solutions enable faster identification of superior traits such as improved yield, fertility, feed efficiency, and disease resistance. Growing concerns around animal health, antimicrobial resistance, and sustainable livestock production are further accelerating the adoption of genetic improvement programs.

Additionally, advancements in AI-based phenotyping, precision livestock farming, sexed semen, and embryo technologies are enhancing breeding accuracy and accelerating genetic gains, while government initiatives to improve livestock productivity in emerging markets are supporting market expansion.

"Bovine embryos are expected to register the highest growth in the embryo market."

The bovine embryos segment is projected to grow at the highest CAGR between 2026 and 2031 with wider implementation of embryo transfer and in vitro fertilization (IVF) techniques across cattle breeding programs. These technologies enable rapid multiplication and distribution of elite genetics from high-performing animals with desirable traits such as enhanced milk yield, improved growth characteristics, better fertility, feed efficiency, and disease resistance. The integration of genomic testing and embryo screening is improving selection precision by identifying embryos with superior genetic potential at an early stage. Expansion of commercial embryo production facilities, veterinary reproductive service providers, and specialized breeding networks is increasing accessibility to bovine embryo technologies. Additionally, standardized embryo evaluation practices and growing cross-border trade of high-value bovine embryos are strengthening genetic improvement initiatives worldwide.

"By end user, animal farms accounted for the largest share of the animal genetics market in 2025."

Animal farms held the largest share of the end-user market in 2025, owing to their central role in the adoption of animal genetics solutions across livestock production systems. Farms are the primary users of genetic materials, including semen and embryos, as well as genetic testing and breeding services to improve productivity, animal health, and breeding efficiency. As genomic data and performance-based selection increasingly influence breeding decisions, farms continue to remain key contributors to demand for genetic improvement solutions across poultry, swine, and dairy operations. This segment is expected to maintain its leading position through 2031, supported by continued adoption of advanced breeding technologies and increasing focus on optimizing livestock performance.

Breakdown of Primaries

The study contains insights from various industry experts. The breakdown of the primaries is as follows:

• By Company Type: Tier 1 - 35%, Tier 2 - 40%, and Tier 3 - 25%
• By Designation: C-Level - 35%, Director Level - 25%, and Others - 40%
• By Region: North America - 40%, Europe - 25%, Asia Pacific - 20%, Middle East & Africa - 8%, Latin America - 7%

Hendrix Genetics BV (Netherlands), Topigs Norsvin (Netherlands), Genus plc (UK), URUS Group LP (US), CRV (Netherlands), Neogen Corporation (US), Eurofins Scientific (Luxembourg), Thermo Fisher Scientific Inc. (US), Illumina, Inc. (US), Select Sires Inc. (US), Groupe Grimaud (France), Zoetis Services LLC (US), Quantum Genetix/Biosciences (Canada), Animal Genetics, Inc. (US), and Semex (Canada).

Research Coverage

This research report categorizes the animal genetics market by live animal (poultry, porcine, bovine, canine, and other live animals), by product & service (animal genetic materials and animal genetic testing services), by technology (NGS, PCR, rDNA, microarrays, and other technologies), by end user (animal farms, veterinary hospitals & clinics, diagnostic centers, and research institutes), and by region.

Further type-level segmentation is available in the full report.

The study also includes an in-depth competitive analysis of the market's key players, their company profiles, key observations related to product and business offerings, recent developments, and key market strategies.

Key Benefits of Buying the Report

The report will provide market leaders and new entrants with the closest approximations of revenue for the overall animal genetics market and its subsegments. It will help stakeholders understand the competitive landscape, gain insights to position their businesses more effectively, and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

The report provides insights into the following pointers:

● Analysis of key drivers (increasing consumption of high-quality animal-derived protein and dairy products, rising focus on improving animal health, livestock productivity, and breeding efficiency through animal genetics, prevention of genetic diseases through advanced genetic services, growing adoption of molecular and genomic tools in livestock improvement programs), restraints (high cost associated with advanced genetic testing, limiting adoption of animal genetic services, technical limitations in accuracy and interpretation of genetic testing technologies), opportunities (untapped market potential in developing countries, integration of advanced phenotyping technologies with genomic selection programs, rising investments in animal genetics research and product innovation), and challenges (developing breed-specific genetic improvement programs for locally adapted animal populations, lack of technical expertise among animal genetics professionals)

● Product Development/Innovation: Detailed insights into upcoming technologies, R&D activities, and new product and service launches in the animal genetics market.

● Market Development: Comprehensive information about lucrative markets-the report analyzes the animal genetics market across varied regions.

● Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the animal genetics market.

● Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players, including Hendrix Genetics BV (Netherlands), Topigs Norsvin (Netherlands), Genus plc (UK), URUS Group LP (US), and CRV (Netherlands)

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
  • 1.3.4 CURRENCY CONSIDERED
• 1.4 STAKEHOLDERS
• 1.5 SUMMARY OF CHANGE

2 EXECUTIVE SUMMARY

• 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
• 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS IN ANIMAL GENETICS MARKET
• 2.4 HIGH GROWTH SEGMENTS
• 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST

3 PREMIUM INSIGHTS

• 3.1 ANIMAL GENETICS MARKET OVERVIEW
• 3.2 ASIA PACIFIC: ANIMAL GENETICS MARKET, BY COUNTRY AND END USER
• 3.3 GEOGRAPHIC SNAPSHOT OF ANIMAL GENETICS MARKET

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Increasing consumption of high-quality animal-derived protein and dairy products
    • 4.2.1.2 Rising focus on improving animal health, livestock productivity and breeding efficiency through animal genetics
    • 4.2.1.3 Prevention of genetic diseases through advanced genetic services
    • 4.2.1.4 Growing adoption of molecular and genomic tools in livestock improvements
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 High cost associated with advanced genetic testing limiting adoption of animal genetic services
    • 4.2.2.2 Technical limitations in accuracy and interpretation of genetic testing technologies
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Untapped market potential in developing countries
    • 4.2.3.2 Integration of advanced phenotyping technologies with genomic selection programs
    • 4.2.3.3 Rising investments in animal genetics research and product innovation
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Developing breed-specific genetic improvement programs for locally adapted animal populations
    • 4.2.4.2 Lack of technical expertise among animal genetics professionals
• 4.3 UNMET NEEDS AND WHITE SPACES
  • 4.3.1 UNMET NEEDS IN ANIMAL GENETICS MARKET
  • 4.3.2 WHITE SPACE OPPORTUNITIES
• 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
  • 4.4.1 INTERCONNECTED MARKETS
  • 4.4.2 CROSS-SECTOR OPPORTUNITIES
• 4.5 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

5 INDUSTRY TRENDS

• 5.1 PORTER'S FIVE FORCES ANALYSIS
  • 5.1.1 THREAT OF NEW ENTRANTS
  • 5.1.2 THREAT OF SUBSTITUTES
  • 5.1.3 BARGAINING POWER OF BUYERS
  • 5.1.4 BARGAINING POWER OF SUPPLIERS
  • 5.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.2 MACROECONOMIC INDICATORS
  • 5.2.1 INTRODUCTION
  • 5.2.2 GDP TRENDS & FORECAST
  • 5.2.3 TRENDS IN GLOBAL ANIMAL HEALTHCARE INDUSTRY
  • 5.2.4 TRENDS IN GLOBAL ANIMAL MEDICAL DEVICE INDUSTRY
• 5.3 SUPPLY CHAIN ANALYSIS
• 5.4 VALUE CHAIN ANALYSIS
• 5.5 ECOSYSTEM ANALYSIS
• 5.6 PRICING ANALYSIS
  • 5.6.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT & SERVICE MARKET (2023-2025)
  • 5.6.2 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY TECHNOLOGY MARKET
  • 5.6.3 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END USER
  • 5.6.4 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY REGION
• 5.7 TRADE ANALYSIS
  • 5.7.1 TRADE DATA FOR HS CODE 051110
    • 5.7.1.1 Import data for HS Code 051110
    • 5.7.1.2 Export data for HS Code 051110
• 5.8 KEY CONFERENCES & EVENTS
• 5.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.10 INVESTMENT & FUNDING SCENARIO
• 5.11 CASE STUDY ANALYSIS
• 5.12 IMPACT OF 2025 US TARIFFS - ANIMAL GENETICS MARKET
  • 5.12.1 INTRODUCTION
  • 5.12.2 KEY TARIFF RATES
  • 5.12.3 PRICE IMPACT ANALYSIS
  • 5.12.4 IMPACT ON COUTRY/REGION
  • 5.12.5 IMPACT ON END-USE INDUSTRIES
    • 5.12.5.1 Animal farms
    • 5.12.5.2 Veterinary hospitals and clinics
    • 5.12.5.3 Diagnostics center
    • 5.12.5.4 Research center

6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS AND FUTURE APPLICATIONS

• 6.1 KEY EMERGING TECHNOLOGIES
  • 6.1.1 CRISPR-CAS9 GENE EDITING
  • 6.1.2 PRECISION PHENOTYPING
• 6.2 COMPLEMENTARY TECHNOLOGIES
  • 6.2.1 ARTIFICIAL INSEMINATION
  • 6.2.2 EMBRYO TRANSFER TECHNOLOGY
• 6.3 ADJACENT TECHNOLOGIES
  • 6.3.1 ARTIFICIAL INTELLIGENCE (AI)
  • 6.3.2 PRECISION LIVESTOCK FARMING
• 6.4 TECHNOLOGY/PRODUCT ROADMAP
  • 6.4.1 NEAR TERM (2025-2027)
  • 6.4.2 MID-TERM (2028-2030)
  • 6.4.3 LONG TERM (2030+)
• 6.5 PATENT ANALYSIS
  • 6.5.1 JURISDICTION & TOP APPLICANT ANALYSIS
• 6.6 FUTURE APPLICATIONS
  • 6.6.1 PRECISION BREEDING AND GENOMIC SELECTION
  • 6.6.2 DEVELOPMENT OF DISEASE-RESISTANT AND HEALTHIER ANIMAL BREEDS
  • 6.6.3 CLIMATE-RESILIENT LIVESTOCK PRODUCTION
  • 6.6.4 CONSERVATION AND RESTORATION OF VALUABLE ANIMAL GENETIC RESOURCES
  • 6.6.5 PERSONALIZED BREEDING PROGRAMS USING AI AND GENOMIC DATA ANALYTICS
• 6.7 IMPACT OF AI/GENERATIVE AI ON ANIMAL GENETICS MARKET
  • 6.7.1 TOP USE CASES AND MARKET POTENTIAL
  • 6.7.2 BEST PRACTICES IN ANIMAL GENETICS MARKET
  • 6.7.3 CASE STUDIES OF AI IMPLEMENTATION IN ANIMAL GENETICS MARKET
  • 6.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS - ANIMAL GENETICS MARKET
  • 6.7.5 CLIENTS' READINESS TO ADOPT GENERATIVE AI IN THE ANIMAL GENETICS

7 SUSTAINABILITY & REGULATORY LANDSCAPE

• 7.1 REGIONAL REGULATIONS & COMPLIANCE
  • 7.1.1 REGULATORY ANALYSIS
    • 7.1.1.1 North America
    • 7.1.1.2 Europe
    • 7.1.1.3 APAC
  • 7.1.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 7.2 INDUSTRY STANDARDS
  • 7.2.1 TESTING LABORATORY COMPETENCE STANDARD - ISO/IEC 17025:2017
  • 7.2.2 QUALITY MANAGEMENT SYSTEM STANDARD - ISO 9001:2015
  • 7.2.3 BIOBANKING OF ANIMAL GERMPLASM STANDARD - ISO 16677-1:2025
  • 7.2.4 BIOTECHNOLOGY - BIOPROCESSING STANDARD - ISO 20688-1:2024
  • 7.2.5 INFORMATION SECURITY MANAGEMENT STANDARD - ISO/IEC 27001:2022
• 7.3 SUSTAINABILITY INITIATIVES
  • 7.3.1 SUSTAINABLE ANIMAL HEALTH AND GENETICS INNOVATION - ZOETIS SERVICES LLC.
  • 7.3.2 ADVANCING SUSTAINABILITY THROUGH ANIMAL GENETICS - GENUS PLC
  • 7.3.3 SUSTAINABILITY IMPACT & REGULATORY POLICY INITIATIVES
  • 7.3.4 CERTIFICATIONS, LABELING, AND ECO-STANDARDS

8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR

• 8.1 DECISION-MAKING PROCESS
• 8.2 KEY STAKEHOLDERS & BUYING CRITERIA
  • 8.2.1 BUYING CRITERIA
• 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES
• 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
• 8.5 MARKET PROFITABILITY

9 ANIMAL GENETICS MARKET, BY LIVE ANIMAL

• 9.1 INTRODUCTION
• 9.2 BOVINE
  • 9.2.1 INCREASING FOCUS ON MAXIMIZING PRODUCTION EFFICIENCY TO DRIVE MARKET
• 9.3 PORCINE
  • 9.3.1 INCREASING APPLICATION OF ADVANCED GENETIC TECHNIQUES TO AID MARKET GROWTH
• 9.4 CANINE
  • 9.4.1 RISING AWARENESS OF GENETIC HEALTH IN DOGS TO SUPPORT GROWTH
• 9.5 POULTRY
  • 9.5.1 RISING DEMAND FOR CHICKEN AND EGG AS PRIMARY PROTEIN SOURCES TO DRIVE MARKET
• 9.6 OTHER LIVE ANIMALS

10 ANIMAL GENETICS MARKET, BY PRODUCT & SERVICE

• 10.1 INTRODUCTION
• 10.2 ANIMAL GENETIC MATERIALS
  • 10.2.1 SEMEN
    • 10.2.1.1 Bovine semen
      • 10.2.1.1.1 Bovine semen to register highest growth rate during study period
    • 10.2.1.2 Porcine semen
      • 10.2.1.2.1 Rising use of artificial insemination to propel market growth
    • 10.2.1.3 Equine semen
      • 10.2.1.3.1 Stringent regulations for disease control to pose challenges for equine industry breeders
    • 10.2.1.4 Canine semen
      • 10.2.1.4.1 Increasing adoption of dogs as companion animals to drive market
    • 10.2.1.5 Other animal semen
  • 10.2.2 EMBRYOS
    • 10.2.2.1 Bovine embryos
      • 10.2.2.1.1 Growing popularity among seed stock and beef producers to support market growth
    • 10.2.2.2 Equine embryos
      • 10.2.2.2.1 Argentina, Brazil, and US to hold leading shares in embryo transfer technology
    • 10.2.2.3 Other animal embryos
• 10.3 ANIMAL GENETIC TESTING SERVICES
  • 10.3.1 GENETIC DISEASE TESTS
    • 10.3.1.1 Genetic disease tests to witness highest growth in testing services market
  • 10.3.2 GENETIC TRAIT TESTS
    • 10.3.2.1 Bovine genetic trait tests
      • 10.3.2.1.1 Focus on high-productivity traits in herds to drive demand
    • 10.3.2.2 Other genetic trait tests
  • 10.3.3 DNA TYPING
    • 10.3.3.1 Emphasis on parentage identification, animal registration, and gender-associated disease identification to propel market
  • 10.3.4 OTHER SERVICES

11 ANIMAL GENETICS MARKET, BY TECHNOLOGY

• 11.1 INTRODUCTION
• 11.2 NGS (NEXT-GENERATION SEQUENCING)
  • 11.2.1 INCREASING APPLICATIONS IN AND RISING GLOBAL DEMAND FOR CHICKEN AND EGGS TO SUPPORT GROWTH
• 11.3 PCR (POLYMERASE CHAIN REACTION)
  • 11.3.1 COST-EFFECTIVENESS, SIMPLICITY, AND HIGH ACCURACY TO DRIVE MARKET
• 11.4 RDNA (RECOMBINANT DNA TECHNOLOGY)
  • 11.4.1 ABILITY TO SUPPORT GENETIC ENGINEERING AND GMOS TO SUPPORT MARKET GROWTH
• 11.5 MICROARRAYS
  • 11.5.1 RAPID ANALYTICAL CAPABILITIES TO PROPEL ADOPTION OF MICROARRAYS
• 11.6 OTHER TECHNOLOGIES

12 ANIMAL GENETICS MARKET, BY END USER

• 12.1 INTRODUCTION
• 12.2 ANIMAL FARMS
  • 12.2.1 GROWING DEMAND FOR ANIMAL-DERIVED FOOD PRODUCTS TO DRIVE MARKET
• 12.3 VETERINARY HOSPITALS & CLINICS
  • 12.3.1 RISING INVESTMENTS AND TECHNOLOGICAL ADVANCEMENTS TO PROPEL GROWTHS
• 12.4 DAIGNOSTIC CENTERS
  • 12.4.1 RISING DEMAND FOR ACCURATE AND TIMELY DIAGNOSIS TO SUPPORT MARKET GROWTH
• 12.5 RESEARCH INSTITUTES
  • 12.5.1 INCREASED FUNDING FOR RESEARCH AND GOVERNMENT INITIATIVES TO DRIVE MARKET

13 ANIMAL GENETICS MARKET, BY REGION

• 13.1 INTRODUCTION
• 13.2 NORTH AMERICA
  • 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 13.2.2 US
    • 13.2.2.1 Adoption of advanced genetic testing methods to drive growth of market
  • 13.2.3 CANADA
    • 13.2.3.1 Growing demand for genetic material to boost market growth
• 13.3 EUROPE
  • 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 13.3.2 GERMANY
    • 13.3.2.1 Growing adoption of genomic breeding and sustainable livestock production drives the animal genetics market
  • 13.3.3 UK
    • 13.3.3.1 Selective breeding programs and efforts to improve breed productivity to drive demand for animal genetics
  • 13.3.4 FRANCE
    • 13.3.4.1 Growing demand for livestock and poultry products drives the animal genetics market
  • 13.3.5 ITALY
    • 13.3.5.1 Government initiatives to conserve indigenous breeds and improve livestock productivity drive market growth
  • 13.3.6 SPAIN
    • 13.3.6.1 Rising demand for pork and poultry products supports the growth of the animal genetics market
  • 13.3.7 NETHERLANDS
    • 13.3.7.1 Strong livestock sector and growing presence of key market players to drive the animal genetics market
  • 13.3.8 REST OF EUROPE
• 13.4 ASIA PACIFIC
  • 13.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 13.4.2 CHINA
    • 13.4.2.1 China to hold largest share of animal genetics market
  • 13.4.3 INDIA
    • 13.4.3.1 Large dairy cattle population and increasing demand for superior genetics drive market growth
  • 13.4.4 JAPAN
    • 13.4.4.1 Increased production and consumption of livestock products to drive market growth
  • 13.4.5 AUSTRALIA
    • 13.4.5.1 Increasing demand for animal-derived food products to propel market growth
  • 13.4.6 SOUTH KOREA
    • 13.4.6.1 Growing demand for premium animal protein and advanced breeding technologies drive market growth
  • 13.4.7 REST OF ASIA PACIFIC
• 13.5 LATIN AMERICA
  • 13.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 13.5.2 BRAZIL
    • 13.5.2.1 Brazil to hold largest share of LATAM market
  • 13.5.3 MEXICO
    • 13.5.3.1 High demand for animal meat to drive market growth in Mexico
  • 13.5.4 REST OF LATIN AMERICA
• 13.6 MIDDLE EAST & AFRICA
  • 13.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 13.6.2 GCC COUNTRIES
    • 13.6.2.1 Emphasis on improving animal welfare standards to support market demand
    • 13.6.2.2 Kingdom of Saudi Arabia
      • 13.6.2.2.1 Kingdom of Saudi Arabia to hold the largest share of the Middle East Animal genetics market
    • 13.6.2.3 United Arab Emirates
      • 13.6.2.3.1 Growing adoption of animal genetics technologies in UAE
    • 13.6.2.4 Rest of GCC Countries
  • 13.6.3 REST OF MIDDLE EAST AND AFRICA

14 COMPETITIVE LANDSCAPE

• 14.1 INTRODUCTION
• 14.2 KEY PLAYER COMPETITIVE STRATEGIES/RIGHT TO WIN, 2024-2026
  • 14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ANIMAL GENETICS MARKET
• 14.3 REVENUE ANALYSIS, 2023-2025
  • 14.3.1 ANIMAL GENETICS MARKET: REVENUE ANALYSIS
• 14.4 MARKET SHARE ANALYSIS, 2025
  • 14.4.1 GLOBAL SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025)
  • 14.4.2 US: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025)
  • 14.4.3 EUROPE: SHARE ANALYSIS FOR ANIMAL GENETICS MARKET (2025)
• 14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
  • 14.5.1 STARS
  • 14.5.2 EMERGING LEADERS
  • 14.5.3 PERVASIVE PLAYERS
  • 14.5.4 PARTICIPANTS
  • 14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025
    • 14.5.5.1 Company footprint
    • 14.5.5.2 Region footprint
    • 14.5.5.3 Live animals footprint
    • 14.5.5.4 Product and services footprint
    • 14.5.5.5 Technology footprint
• 14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
  • 14.6.1 PROGRESSIVE COMPANIES
  • 14.6.2 RESPONSIVE COMPANIES
  • 14.6.3 DYNAMIC COMPANIES
  • 14.6.4 STARTING BLOCKS
  • 14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES
    • 14.6.5.1 Detailed list of key startups/SMEs
    • 14.6.5.2 Competitive benchmarking of key startups/SMEs
• 14.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 14.7.1 FINANCIAL METRICS
  • 14.7.2 COMPANY VALUATION
• 14.8 BRAND/PRODUCT COMPARISON
• 14.9 COMPETITIVE SCENARIO
  • 14.9.1 PRODUCT LAUNCHES & APPROVALS
  • 14.9.2 DEALS
  • 14.9.3 EXPANSIONS
  • 14.9.4 OTHER DEVELOPMENTS

15 COMPANY PROFILES

• 15.1 KEY PLAYERS
  • 15.1.1 GENUS PLC
    • 15.1.1.1 Business overview
    • 15.1.1.2 Products/Service offered
    • 15.1.1.3 Recent developments
      • 15.1.1.3.1 Product/Service launches & approvals
      • 15.1.1.3.2 Deals
      • 15.1.1.3.3 Other developments
    • 15.1.1.4 MnM view
      • 15.1.1.4.1 Right to win
      • 15.1.1.4.2 Strategic choices
      • 15.1.1.4.3 Weaknesses and competitive threats
  • 15.1.2 NEOGEN CORPORATION
    • 15.1.2.1 Business overview
    • 15.1.2.2 Products /Services offered
    • 15.1.2.3 Recent developments
      • 15.1.2.3.1 Product/Service launches and approvals
      • 15.1.2.3.2 Deals
      • 15.1.2.3.3 Expansions
    • 15.1.2.4 MnM view
      • 15.1.2.4.1 Right to win
      • 15.1.2.4.2 Strategic choices
      • 15.1.2.4.3 Weaknesses and competitive threats
  • 15.1.3 EUROFINS SCIENTIFIC
    • 15.1.3.1 Business overview
    • 15.1.3.2 Products/Services offered
    • 15.1.3.3 Recent developments
      • 15.1.3.3.1 Deals
    • 15.1.3.4 MnM view
      • 15.1.3.4.1 Right to win
      • 15.1.3.4.2 Strategic choices
      • 15.1.3.4.3 Weaknesses and competitive threats
  • 15.1.4 THERMO FISHER SCIENTIFIC INC
    • 15.1.4.1 Business overview
    • 15.1.4.2 Products/Services offered
    • 15.1.4.3 Recent developments
      • 15.1.4.3.1 Product/Services launches and approvals
    • 15.1.4.4 MnM view
      • 15.1.4.4.1 Right to win
      • 15.1.4.4.2 Strategic choices
      • 15.1.4.4.3 Weaknesses and competitive threats
  • 15.1.5 ZOETIS SERVICES LLC
    • 15.1.5.1 Business overview
    • 15.1.5.2 Products/Services offered
    • 15.1.5.3 Recent developments
      • 15.1.5.3.1 Product & Service launches
      • 15.1.5.3.2 Deals
      • 15.1.5.3.3 Other developments
  • 15.1.6 ILLUMINA, INC.
    • 15.1.6.1 Business overview
    • 15.1.6.2 Products/Services offered
  • 15.1.7 HENDRIX GENETICS BV
    • 15.1.7.1 Business overview
    • 15.1.7.2 Products/Services offered
    • 15.1.7.3 Recent developments
      • 15.1.7.3.1 Product & Service launches
      • 15.1.7.3.2 Deals
      • 15.1.7.3.3 Expansions
      • 15.1.7.3.4 Other developments
  • 15.1.8 CRV
    • 15.1.8.1 Business overview
    • 15.1.8.2 Products/Services offered
    • 15.1.8.3 Recent developments
      • 15.1.8.3.1 Product/Services launches and approvals
      • 15.1.8.3.2 Deals
  • 15.1.9 TOPIGS NORSVIN EN
    • 15.1.9.1 Business overview
    • 15.1.9.2 Products/Services offered
    • 15.1.9.3 Recent developments
      • 15.1.9.3.1 Product/Service launches & approvals
      • 15.1.9.3.2 Deals
      • 15.1.9.3.3 Expansions
      • 15.1.9.3.4 Other developments
  • 15.1.10 URUS GROUP LP
    • 15.1.10.1 Business overview
    • 15.1.10.2 Products/Services offered
    • 15.1.10.3 Recent developments
      • 15.1.10.3.1 Product/Services launches and approvals
      • 15.1.10.3.2 Deals
      • 15.1.10.3.3 Expansions
    • 15.1.10.4 MnM view
      • 15.1.10.4.1 Right to win
      • 15.1.10.4.2 Strategic choices
      • 15.1.10.4.3 Weaknesses and competitive threats
  • 15.1.11 SELECT SIRES INC.
    • 15.1.11.1 Business overview
    • 15.1.11.2 Products/Services offered
    • 15.1.11.3 Recent developments
      • 15.1.11.3.1 Product/Services launches and approvals
      • 15.1.11.3.2 Deals
  • 15.1.12 GROUPE GRIMAUD
    • 15.1.12.1 Business overview
    • 15.1.12.2 Products/Services offered
    • 15.1.12.3 Recent developments
      • 15.1.12.3.1 Expansions
      • 15.1.12.3.2 Other developments
  • 15.1.13 QUANTUM GENETIX/BIOSCIENCES
    • 15.1.13.1 Business overview
    • 15.1.13.2 Products/Services offered
    • 15.1.13.3 Recent developments
      • 15.1.13.3.1 Other developments
  • 15.1.14 ANIMAL GENETICS, INC.
    • 15.1.14.1 Business overview
    • 15.1.14.2 Products/Services offered
  • 15.1.15 SEMEX
    • 15.1.15.1 Business overview
    • 15.1.15.2 Products/Services offered
    • 15.1.15.3 Recent developments
      • 15.1.15.3.1 Deals
      • 15.1.15.3.2 Expansions
• 15.2 OTHER PLAYERS
  • 15.2.1 LABOKLIN GMBH & CO. KG
  • 15.2.2 DANBRED P/S
  • 15.2.3 TROPICAL ANIMAL GENETICS
  • 15.2.4 INGURAN LLC DBA STGENETICS
  • 15.2.5 SUPERIOR ANIMAL GENETICS
  • 15.2.6 XYTOVET
  • 15.2.7 SWINE GENETICS INTERNATIONAL
  • 15.2.8 GENERATIO GMBH
  • 15.2.9 GENSOL DIAGNOSTICS, LLC.
  • 15.2.10 SANDOR ANIMAL BIOGENICS PVT. LTD.

16 RESEARCH METHODOLOGY

• 16.1 RESEARCH DATA
  • 16.1.1 SECONDARY DATA
  • 16.1.2 PRIMARY DATA
    • 16.1.2.1 Breakdown of primary interviews
    • 16.1.2.2 Key industry insights
• 16.2 MARKET SIZE ESTIMATION
  • 16.2.1 APPROACH 1: COMPANY REVENUE ANALYSIS APPROACH
  • 16.2.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
  • 16.2.3 BOTTOM-UP APPROACH: SUPPLY-SIDE ANALYSIS
  • 16.2.4 TOP-DOWN APPROACH
  • 16.2.5 BASE NUMBER CALCULATION
    • 16.2.5.1 Company presentations
    • 16.2.5.2 Primary interviews
  • 16.2.6 VOLUME ESTIMATION
  • 16.2.7 DEMAND-SIDE APPROACH
• 16.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 16.4 MARKET SHARE ASSESSMENT
• 16.5 RESEARCH ASSUMPTIONS
  • 16.5.1 STUDY ASSUMPTIONS
  • 16.5.2 GROWTH RATE ASSUMPTIONS
• 16.6 RISK ASSESSMENT
  • 16.6.1 RESEARCH LIMITATIONS

17 APPENDIX

• 17.1 DISCUSSION GUIDE
• 17.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 17.3 CUSTOMIZATION OPTIONS
• 17.4 RELATED REPORTS
• 17.5 AUTHOR DETAILS